China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,129 | 12,077 | 17,369 | 15,570 | 13,359 |
| Receivables | 1,719 | 1,315 | 1,345 | 3,333 | 4,507 |
| Inventories | 828 | 795 | 531 | 1,018 | 860 |
| Other current assets | 301 | 15 | 46 | 1,667 | 2,649 |
| TOTAL | $21,297 | $14,233 | $19,521 | $22,452 | $23,234 |
| Non-Current Assets | |||||
| PPE Net | 179 | 329 | 962 | 1,228 | 1,434 |
| Investments And Advances | 0 | 8,310 | 8,737 | 9,465 | 9,158 |
| Intangibles | 12 | 19 | 28 | 39 | 46 |
| Other Non-Current Assets | 177 | 236 | 306 | 363 | 677 |
| TOTAL | $367 | $8,894 | $10,033 | $11,094 | $11,314 |
| Total Assets | $21,664 | $23,127 | $29,554 | $33,546 | $34,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 711 | 2,295 | 3,333 | 2,046 | 37 |
| Accounts payable and accrued liabilities | 1,158 | 2,327 | 6,582 | 10,178 | 13,605 |
| Accrued Expenses | 2,938 | 2,768 | 3,142 | 3,530 | 3,047 |
| Other current liabilities | 113 | 401 | 278 | 200 | 730 |
| TOTAL | $6,012 | $8,902 | $14,497 | $17,122 | $18,580 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96 | 117 | 118 | N/A | 6 |
| Other Non-Current Liabilities | 115 | 178 | 248 | 0 | 0 |
| TOTAL | $212 | $295 | $366 | $N/A | $6 |
| Total Liabilities | $6,224 | $9,197 | $14,863 | $17,122 | $18,586 |
| Shareholders' Equity | |||||
| Common Shares | 44,531 | 39,668 | 914 | 163 | 62 |
| Retained earnings | -28,015 | -24,712 | -21,613 | -15,688 | -9,952 |
| Other shareholders' equity | -1,076 | -1,026 | -198 | 956 | 528 |
| TOTAL | $15,440 | $13,931 | $14,691 | $16,425 | $15,961 |
| Total Liabilities And Equity | $21,664 | $23,127 | $29,554 | $33,546 | $34,548 |